Universe Pharmaceuticals (Universe Pharmaceuticals) Net Cash per Share : $1.30 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Universe Pharmaceuticals Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Universe Pharmaceuticals's Net Cash per Share for the quarter that ended in Sep. 2023 was $1.30.

The historical rank and industry rank for Universe Pharmaceuticals's Net Cash per Share or its related term are showing as below:

UPC' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.73 Med: 2.13 Max: 5.08
Current: 1.85

During the past 6 years, the highest Price-to-Net-Cash Ratio of Universe Pharmaceuticals was 5.08. The lowest was 0.73. And the median was 2.13.

UPC's Price-to-Net-Cash is ranked better than
93.55% of 248 companies
in the Drug Manufacturers industry
Industry Median: 7.355 vs UPC: 1.85

Universe Pharmaceuticals Net Cash per Share Historical Data

The historical data trend for Universe Pharmaceuticals's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universe Pharmaceuticals Net Cash per Share Chart

Universe Pharmaceuticals Annual Data

Trend

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Net Cash per Share

Get a 7-Day Free Trial

-0.65

0.59

2.92

1.59

1.30

Universe Pharmaceuticals Semi-Annual Data
	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Net Cash per Share	Get a 7-Day Free Trial						2.92	5.07	1.59	0.84	1.30

Competitive Comparison of Universe Pharmaceuticals's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Universe Pharmaceuticals's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universe Pharmaceuticals's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Universe Pharmaceuticals's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Universe Pharmaceuticals's Price-to-Net-Cash falls into.

Universe Pharmaceuticals Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Universe Pharmaceuticals's Net Cash per Share for the fiscal year that ended in Sep. 2023 is calculated as

	Net Cash per Share (A: Sep. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(18.504	-	13.754	-	0)	/	3.64597
=	1.30

Universe Pharmaceuticals's Net Cash per Share for the quarter that ended in Sep. 2023 is calculated as

	Net Cash per Share (Q: Sep. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(18.504	-	13.754	-	0)	/	3.64597
=	1.30

Universe Pharmaceuticals (NAS:UPC) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Universe Pharmaceuticals Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Universe Pharmaceuticals's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Universe Pharmaceuticals (Universe Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Universe Pharmaceuticals Inc (NAS:UPC) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

265 Jingjiu Avenue, Economic & Technological Development Zone, Jinggangshan, Jiangxi, Ji’an, CHN

Website

http://www.universe-pharmacy.com

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.